Initial visits typically run $150-250 (cash-pay or superbill for out-of-network reimbursement)
Key research findings include: GLP-1 medications do not prevent the natural reduction in resting energy expenditure that accompanies weight loss The primary mechanism remains caloric restriction through enhanced satiety Improvements in metabolic health markers (insulin sensitivity, lipid profiles) occur secondary to weight loss rather than direct metabolic stimulation No evidence supports claims that these medications 'reset' or permanently increase baseline metabolism For lipotropic injections, high-quality randomised controlled trials are notably absent
Canada is the only country where Novo Nordisk allowed the patent for its semaglutide drugs to expire, paving the way for regulatory exclusivity to end on Jan
High-histamine foods like bone broth, kimchi, kombucha, and leftovers can cause issues when your gut lining is still inflamed or compromised
It can cause constipation, which creates the environment where an infection (diverticulitis) is more likely to occur
Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials